Breaking News Instant updates and real-time market news.

ADM

Archer Daniels

$42.52

-0.09 (-0.21%)

10:38
03/25/19
03/25
10:38
03/25/19
10:38

Archer Daniels sees negative impact of $50M-$60M in Q1 from extreme weather

In a regulatory filing, Archer Daniels said "Extreme winter weather has affected our first quarter North American operations beyond what we would experience in a typical winter. In March, powerful snow and rain storms early in the month and resulting flooding and its after-effects are affecting both Carbohydrates Solutions and Origination operations. Rail transportation has been disrupted throughout the region; our corn processing complex in Columbus, Nebraska, was idled due to flooding and currently is running at reduced rates; and unfavorable river conditions since December are severely limiting barge transportation movements and port activities. Earlier in the quarter, severe cold temperatures and snowstorms affected some of our Carbohydrate Solutions processing facilities in the Midwest. The extreme weather reduced corn processing volumes principally due to a slowdown in rail and truck transportation, which affected both inbound and outbound shipments. We continue to assess the situation, and utilize our transportation and operating network as much as possible to meet customer needs. Taken together, we expect these severe weather disruptions to have a negative pre-tax operating profit impact to ADM of $50M-$60M for the first quarter. That impact will be roughly equal between Carbohydrate Solutions and Origination, with some minor impacts to our other segments. We will have a further update on our first quarter 2019 earnings call, with an assessment of full year impacts, including recoveries and offsets."

  • 25

    Mar

  • 27

    Mar

ADM Archer Daniels
$42.52

-0.09 (-0.21%)

11/08/18
11/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Archer Daniels (ADM) upgraded to Buy from Hold at Argus with analyst Deborah Ciervo citing the company's recent strong performance and improvement in its Oilseeds, Origination, and Nutrition divisions. 2. Ultragenyx (RARE) upgraded to Neutral from Sell at Citi with analyst Yigal Nochomovitz saying his long-standing concerns on Ultragenyx's valuation "have substantially played out with recent pipeline disclosures having rapidly reset the valuation." 3. Medifast (MED) upgraded to Buy from Neutral at Sidoti. 4. Knight-Swift (KNX) upgraded to Buy from Neutral at Goldman Sachs with analyst Matthew Reustle saying he is bullish on Knight citing incremental evidence that the merger with Swift Transportation will deliver margin improvement through the end of the decade, reduced investor expectations following recent estimate revisions, and a view that Knight is more defensive through a down-cycle with a de-risked valuation. 5. Axon (AAXN) Enterprise upgraded to Overweight from Neutral at JPMorgan with analyst Mark Strouse saying the stock pulled back 16% yesterday following the company's Q3 results and guidance that implies a dip in revenue growth during Q4. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/23/19
FBCO
01/23/19
NO CHANGE
Target $46
FBCO
Neutral
Archer Daniels price target lowered to $46 from $52 at Credit Suisse
Credit Suisse analyst Robert Moskow lowered his price target for Archer Daniels to $46 from $52 to reflect his concerns with declining crush margins as well as the possibility of declining soybean meal demand from China due to African swine fever. The analyst reiterates a Neutral rating on the shares.
02/08/19
STFL
02/08/19
UPGRADE
Target $52
STFL
Buy
Archer Daniels upgraded to Buy from Hold at Stifel
Stifel analyst Vincent Anderson upgraded Archer Daniels Midland to Buy while lowering his price target for the shares to $52 from $55. The stock at current levels largely price in the company's tough comps in soybean crush margins while undervaluing its potential earnings growth from "controllables" as the company shifts its focus to digesting recent acquisitions, Anderson tells investors in a research note. Further, Archer Daniels shares currently trade at the low end of their historical forward price-to-earnings range and trailing 52 week share price range, adds the analyst. He sees upside potential of around 23%.
02/08/19
02/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. GrubHub (GRUB) upgraded to Buy from Neutral at BofA/Merrill and Roth Capital. 2. Willis Towers Watson (WLTW) upgraded to Hold from Sell at Deutsche Bank with analyst Joshua Shanker saying with 2018 coming to a close, the free cash flow content of Willis Towers Watson's earnings has improved to a point where the "valuation discount to its peers is no longer materially under-representative." 3. Archer Daniels (ADM) upgraded to Buy from Hold at Stifel with analyst Vincent Anderson saying the stock at current levels largely price in the company's tough comps in soybean crush margins while undervaluing its potential earnings growth from "controllables" as the company shifts its focus to digesting recent acquisitions. 4. Rayonier (RYN) upgraded to Market Perform from Underperform at BMO Capital with analyst Mark Wilde citing valuation as the key driver of the upgrade. 5. Broadridge (BR) upgraded to Buy from Neutral at DA Davidson with analyst Peter Heckmann saying the 30% retreat in the stock price has made valuation more attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DHR

Danaher

$151.34

1.58 (1.06%)

, GE

General Electric

$11.44

0.46 (4.19%)

08:55
12/13/19
12/13
08:55
12/13/19
08:55
Options
Notable open interest changes for December 13th »

Thursday's total…

DHR

Danaher

$151.34

1.58 (1.06%)

GE

General Electric

$11.44

0.46 (4.19%)

AMD

AMD

$42.61

3.16 (8.01%)

NVST

Envista

$28.47

0.29 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

LULU

Lululemon

$224.48

-8.83 (-3.78%)

08:52
12/13/19
12/13
08:52
12/13/19
08:52
Recommendations
Lululemon analyst commentary  »

Lululemon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

08:51
12/13/19
12/13
08:51
12/13/19
08:51
Conference/Events
Credit Suisse economists/strategists to hold an analyst/industry conference call »

Economists and…

TREE

LendingTree

$293.67

-13 (-4.24%)

08:51
12/13/19
12/13
08:51
12/13/19
08:51
Recommendations
LendingTree analyst commentary  »

Stephens says LendingTree…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$30.95

-0.77 (-2.43%)

08:50
12/13/19
12/13
08:50
12/13/19
08:50
Initiation
Sinclair Broadcast initiated  »

Sinclair Broadcast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEVI

Levi Strauss

$18.41

0.39 (2.16%)

08:49
12/13/19
12/13
08:49
12/13/19
08:49
Recommendations
Levi Strauss analyst commentary  »

Levi Strauss price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$6.98

-0.27 (-3.72%)

08:48
12/13/19
12/13
08:48
12/13/19
08:48
Syndicate
Universal Technical 3.6M share Spot Secondary priced at $6.25 »

B. Riley FBR acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

08:46
12/13/19
12/13
08:46
12/13/19
08:46
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:45
12/13/19
12/13
08:45
12/13/19
08:45
General news
U.S. import prices increased 0.2% »

U.S. import prices…

AMC

AMC Entertainment

$8.29

0.12 (1.47%)

, SCO

Scor ADR

$13.01

-0.21 (-1.59%)

08:45
12/13/19
12/13
08:45
12/13/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

AMC

AMC Entertainment

$8.29

0.12 (1.47%)

SCO

Scor ADR

$13.01

-0.21 (-1.59%)

PLCE

Children's Place

$58.26

4.46 (8.29%)

CHWY

Chewy

$27.95

1.08 (4.02%)

TLRY

Tilray

$18.87

0.68 (3.74%)

BLDP

Ballard Power

$6.17

0.095 (1.56%)

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$12.68

0.11 (0.88%)

GTT

GTT Communications

$12.01

-0.36 (-2.91%)

Z

Zillow

$42.51

-0.22 (-0.51%)

SVXY

ProShares Short VIX Short-Term Futures

$63.16

1.65 (2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

08:45
12/13/19
12/13
08:45
12/13/19
08:45
General news
U.S. retail sales increased 0.2% in November, and were up 0.1% excluding autos »

U.S. retail sales…

08:45
12/13/19
12/13
08:45
12/13/19
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

VCTR

Victory Capital

$21.68

0.235 (1.10%)

08:44
12/13/19
12/13
08:44
12/13/19
08:44
Downgrade
Victory Capital rating change  »

Victory Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$5.08

0.16 (3.25%)

08:43
12/13/19
12/13
08:43
12/13/19
08:43
Conference/Events
Corbus Pharmaceuticals to hold a webinar »

Expert panel discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

EV

Eaton Vance

$47.08

0.395 (0.85%)

08:42
12/13/19
12/13
08:42
12/13/19
08:42
Upgrade
Eaton Vance rating change  »

Eaton Vance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTMI

TTM Technologies

$13.79

0.19 (1.40%)

08:41
12/13/19
12/13
08:41
12/13/19
08:41
Upgrade
TTM Technologies rating change  »

JPMorgan upgrades TTM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$94.63

0.16 (0.17%)

08:39
12/13/19
12/13
08:39
12/13/19
08:39
Conference/Events
Arthur J. Gallagher to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

NEWR

New Relic

$66.87

0.86 (1.30%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Recommendations
New Relic analyst commentary  »

Morgan Stanley came way…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMK

AssetMark Financial

$27.31

0.42 (1.56%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Upgrade
AssetMark Financial rating change  »

JPMorgan upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$259.14

0.71 (0.27%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Conference/Events
Lennox to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VIAC

ViacomCBS

$37.79

0.52 (1.40%)

08:36
12/13/19
12/13
08:36
12/13/19
08:36
Initiation
ViacomCBS initiated  »

ViacomCBS reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$2.23

0.12 (5.69%)

08:35
12/13/19
12/13
08:35
12/13/19
08:35
Hot Stocks
Cellectar Biosciences presents data on CLR 2000045 at AACR symposium »

Cellectar Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCFT

OneConnect

$0.00

(0.00%)

08:35
12/13/19
12/13
08:35
12/13/19
08:35
Syndicate
OneConnect 31.2M share IPO priced at $10.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ONCS

OncoSec

$2.39

-0.04 (-1.65%)

, MRK

Merck

$88.95

0.6 (0.68%)

08:34
12/13/19
12/13
08:34
12/13/19
08:34
Hot Stocks
OncoSec reports interim results from KEYNOTE-890 study »

OncoSec announced interim…

ONCS

OncoSec

$2.39

-0.04 (-1.65%)

MRK

Merck

$88.95

0.6 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

CFX

Colfax

$35.74

0.6 (1.71%)

08:34
12/13/19
12/13
08:34
12/13/19
08:34
Conference/Events
Colfax to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.